BeOne Medicines Ltd.
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Accrued Sales Rebates & Returns Reserve by Year
Accrued Sales Rebates & Returns Reserve — Ending Balance ($M) ($M)
BeOne Medicines Accrued Sales Rebates & Returns Reserve: $399M in FY2025, up 69.1% from a year earlier. That is the highest of the 10 years on record here.
Where the FY2025 figure comes from
Source: Form 10-Q (filed 2026-08-05) ↗
Reported in Form 10-Q / 10-K Accrued Sales Rebates Rollforward Note (XBRL).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Accrued Sales Rebates & Returns Reserve — Ending Balance ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 399 | +69.1% | Form 10-Q (filed 2026-08-05) ↗ |
| FY2024 | Dec 31, 2024 | 236 | +68.4% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 140 | +234.7% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 41.8 | -29.9% | Form 10-Q (filed 2024-11-12) ↗ |
| FY2021 | Dec 31, 2021 | 59.6 | +400.8% | Form 10-K (filed 2024-02-26) ↗ |
| FY2020 | Dec 31, 2020 | 11.9 | +271.9% | Form 10-K (filed 2023-02-27) ↗ |
| FY2019 | Dec 31, 2019 | 3.20 | -33.3% | Form 10-K (filed 2022-02-28) ↗ |
| FY2018 | Dec 31, 2018 | 4.80 | +20.0% | Form 10-K (filed 2021-02-25) ↗ |
| FY2017 | Dec 31, 2017 | 4 | – | Form 10-K (filed 2020-03-02) ↗ |
| FY2016 | Dec 31, 2016 | 0 | – | Form 10-K (filed 2019-02-28) ↗ |
Breakdown
What makes up accrued Sales Rebates & Returns Reserve
Cite this data
StockData. (2026). BeOne Medicines Accrued Sales Rebates & Returns Reserve ($M), annual FY2016–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/gtn-reserve-ending
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.